Podcast Center
Video Center
Webcasts
Resource Center
Events
February 03, 2016 at 07:29 AM
(Bloomberg) — “Price-gouging.” “Predatory.” “Outrageous.” Those are just a few of the barbs presidential candidates, including Hillary Clinton, have thrown the way of the pharmaceutical industry this campaign season.
That rhetoric helped sink drug and biotech stocks over the last six months and has overshadowed the candidates’ criticism of the rest of the health care system, including insurers. Yet those businesses could be just as much at risk if the next president, whoever that may be, persists in calling out health care companies on cost.
Investors may want to start paying more attention in particular to Clinton, who emerged from Tuesday’s Iowa caucus in a virtual tie with Democratic rival Bernie Sanders.
“She has a real interest in finding ways to make sure that we keep what people pay for health insurance premiums and what they pay out-of-pocket affordable,” said Ken Thorpe, a health policy professor at Emory University who worked in Bill Clinton’s administration.
Clinton made that clear during a recent event in Iowa. “People may remember that I took on the health insurance industry back in the nineties,” she said.
Spreading criticism
Her campaign proposal calls for insurers to control costs for health plan members, in part by limiting out-of-pocket expenses. She also wants more government authority to limit health insurance premiums, and has called for scrutiny of big insurer mergers.
Ian Sams, a spokesman for Clinton, declined to comment.
In a radio ad for her campaign, a narrator promises that “Hillary will take on the drug and insurance companies to lower health care costs.” One of her TV commercials, focused on a boy whose family pays $400 a month in medical and drug costs, hits on “premiums, deductibles and co-pays that keep adding up,” calling for insurers to “cap out-of-pocket costs.”
“We’ve got to get health care costs under control,” Clinton has said. And on Twitter, she weighed in on a National Public Radio article about pharmacy benefit managers such as Express Scripts Holding Co. (Nasdaq:ESRX) that push some customers to switch drug regimens. “Companies like these should be ashamed,” Clinton said.
See also: Harms of price hikes for old drugs detailed at Senate panel
David Whitrap, an Express Scripts spokesman, declined to comment on Clinton’s tweet. The company is “proud of our proven solutions to make medicine more affordable and accessible,” he said.
To be sure, most of the candidates’ proposals would cement the role of private insurers in managing the U.S. health care system. Ted Cruz, who came in first among Republicans in Iowa, wants to repeal the 2010 Patient Protection and Affordable Care Act, expand the role of tax-advantaged savings accounts to help people pay for care, and let insurance companies offer policies across state lines.
